The Future of the Global Pharmaceutical Industry October 2017. Future of Pharma Disruptive technologies and emerging trends such as robotics, artificial intelligence, 3D printing, precision medicine or patient design will impact the manufacturing and distribution of pharmaceuticals. Well, beware. Compliance is an essential subset of the tools required for excellence. Coupling insight from interviews with senior pharma executives and our own secondary research, this paper explores how four key trends are in turn shaping four critical capabilities required for the future. A study of the shape of the global pharma sector 3. The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. When a (usually) fresh-faced consultant asks lots of questions and fills in a spreadsheet comparing what you do with your competitors. BACK TO BASICS: HOW TO PROSPER IN AN UNCERTAIN WORLD. Changing R&D models in research-based pharma companies. Around the world, people are living longer. The future success of today’s market leaders will be determined by how they react to these changes. When we have simple systems, motivation improves, errors fall and productivity increases. Who knows? The breakthrough in the search for a coronavirus vaccine highlights the speed with which the pharmaceutical industry can mobilise scientific ingenuity in the service of humankind’s core goals. Your email address will not be published. More than 220 drugs are expected to be introduced in the pharma market by 2021. Remember less is more. After all, 20 years ago we were told to expect a paperless society, flying cars and more leisure time by now! NSF International's expert Martin Lush gives his insight into the political landscape and the future of the pharmaceutical industry. In some clinics AI can do a lot better. Now, the question is how AI and ML will help to reshape the future of the pharmaceutical industry. Batch processing is tried and tested, and has been used as the industry standard for decades. Assuming that what worked last year will work in the future is also very risky. It is clear that we are reaching one end of a paradigm, but what most people still do not get is how big the oncoming changes will be. We all help each other and collaborate like never before. The Future of The Pharmaceutical Industry. The … AI and wearable devices will allow medical interventions to be made earlier to cut back on treatment and hospital costs. Of course, my predictions for the future are based on educated guesswork and whether they happen or not remains to be seen. We have to admit risks and manage them intelligently and quickly. Future of the Global Pharmaceutical Industry Torreya finds the global pharmaceutical industry is larger, innovating more rapidly, and likely to experience higher growth than previously thought. Your education programs must focus on providing the skills that will matter most: emotional intelligence, risk-based decision making, critical thinking and problem solving. Governmentswill have to take a radically different approach to pricing and reimbursement unless they want society to return to the pre-antibiotic era. Journal of Translational Medicine, 2016;14:105; doi: 10.1186/s12967-016-0838-4. Pharma currently spends, on average, $1.3 billion bringing a new medicine to market with an attrition rate of 90 percent. They are more likely to vote for politicians who promise to meet their healthcare needs. The future of compliant commerce in HLS is here. Wearable devices will put patients center stage and in greater control of their own healthcare. By 2013 it had tripled to 18 percent of GDP. Reshaping the future of pharma 5. We need to recruit and develop risk-smart leaders at every level and get them onto the shop floor. Spread the love. Executive Summary 3 2. It’s not. Subscribe to the weekly Policy Currents newsletter to receive updates on the issues that matter most. And which other countries would likely benefit? Some people may have the attitude of ‘if it isn’t broke, don’t try to fix it’ and question the need to change a process that has produced profitable results for such a long time. Rashi Sharma; Getty. I recently presented the 30-minute webinar The Political Landscape and the Future of the Pharma Industry available in our resource library (. ) Learn how @LSIntegrates' #PharmaIntegrates helped innovation to continue through an unprecedented year in our latest #ForefrontPharma @ChemistryWorld supplement ✨ https://www.chemistryworld.com/forefront-of-pharma/the-future-is-bright-protecting-innovation-during-uncertain-times/4012742.article, #Medtech companies are operating in a relatively new ecosystem that does not yet provide clear paths to monetisation. Competitive pressure requires rapid organizational changes. While recent pharmaceutical industry trends in Canada have been challenged with poor market growth and pressures from global competition, there still remains a very viable industry which if aided by stronger industrial sector support can flourish and successfully compete in this new and much more globally competitive business environment. Decode the Future of the Pharmaceutical Industry We have decades of experience in being the trusted, gold standard intelligence provider to leading Pharmaceutical brands, manufacturers, and suppliers, helping them to make faster, more informed decisions. We must become risk-smart. Pricing and reimbursement schemes will drastically change. Pharmaceutical and GMP Manufacturing Professionals are encouraged to submit registrations for the 2020 GMP Forum event being held in August (Melbourne) as soon as possible to update their awareness of industry changes impacting the future of manufacturing industries including the future of pharmaceutical manufacturing and medical device/veterinary medicine manufacturing (Pharma 4.0). I recently presented the 30-minute webinar The Political Landscape and the Future of the Pharma Industry available in our resource library (www.nsf.org/info/pblibrary) under Webinars. Models for open innovation in the pharmaceutical industry. A panel of distinguished experts explores key changes that lie ahead for pharmaceutical and biotechnology companies in R&D, drug development, new technology, profitability and the regulatory arena as they prepare for the competitive environment of the 21st century. When we look back on the sector 20 years from now, we may describe our current approach to disease and treatments as crude. The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. IoT and big data to prevent pandemics in the future Apart from addressing the above mentioned and other challenges and reaching all planned goals, the pharmaceutical industry is burdened with the pandemic crisis, which will continue dictating its rules for the industry for at least the nearest future. [4] Schuhmacher A et al. 3D-printed drugs. The focus must be on prevention, not reaction, by designing out errors and mistakes in the first place and by brutally simplifying everything. We get back to basics and break old, outdated habits. Most companies’ training programs just tick the compliance box and change little. Everyone will be impacted. I leave the most important and hardest to last. More sustainable and scalable ways of incentivizing innovation in response to infectious disease threats are needed. Medics have only 20 percent accuracy. By Kevin Robinson 1-Feb-2019. According to the BBC, Dr. Kees de Joncheere from the World Health Organization stated, “The system [pharmaceutical industry] has served us well … Our world needs more economies of scale to achieve greater effciencies. Since 2007, Future Pharmaceutical industries has been established to be a unique business in Egypt. The companies that will succeed in the future will, in my opinion, do the following exceptionally well. The pharma industry continues to evolve, with potential disruptions affecting all parts of the value chain, from R&D to patient care. What Is The Future Of Pharma? Is it arrogance or ignorance? Drug Discovery Today, 2010;18: 1133-1137 Explore what the future of the pharmaceutical industry holds and how health interventions may impact business models in life sciences. Old behaviors remain. Unless we collaborate, we won’t make it. The digital future in the pharmaceutical industry starts now Comprehensive approach The pace of innovation and the ability to disrupt are becoming key success factors in global competition. For me it all boils down to simple economics: In 1960 healthcare represented less than 6 percent of the U.S. economy. The future model for pharma can be visualised as a continuum at one end of which is the company that is about delivery of molecules to market that generate revenues through profits from providing therapeutic solutions to ill people. Download This WhitePaper: The Future of the Pharmaceutical Industry. It directly employs some 795,000 people and generates about three times more employment indirectly – upstream and downstream – than it does directly (PwC, Economic and societal footprint of the pharmaceutical industry in Europe, June 2019). Pharmaceutical Blockchain Market 2020– Industry Trends, Manufacturers and Future Development Report 12-15-2020 01:00 PM CET | Health & Medicine Press release from: ReportsnReports 3. The healthcare sector is the one that undergoes a whole lot of changes on a regular basis. Much of the current regulatory framework is no longer ft for purpose and is guilty of stifling innovation when we need it most. Aatmanirbhar Bharat; Active Pharmaceutical Ingredients; API; COVID19 ; FDA; COVID-19 pandemic is not only a global health catastrophe, it is also a hard-hitting economic crisis for several economies. THE FUTURE OF THE PHARMACEUTICAL INDUSTRY Ever participated in one of those benchmarking exercises? Future of the Pharmaceutical Industry How a pharmaceutical manufacturing software helps to manage your business The pharmaceutical industry is one of the most agile industries and is prone to more changes. by Life Science Integrates | Jan 15, 2019 | White Paper | 0 comments. By 2030, we should not simply expect more targeted therapies, practitioners will also be able to predict the likelihood of a patient being diagnosed with a disease or health condition, and shift from treatment of … You know what I mean. Pharma 2020: Marketing the future - Which path will you take? It is clear that we are reaching one end of a paradigm, but what most people still do not get is how big the oncoming changes will be. Pharmaceutical companies that are able to reimagine their traditional business model may be most likely to succeed in a future built around prevention, early detection, and personalized therapies. But then again, I have been telling myself that for the last 20 years. In the UK the total proportion of GDP dedicated to healthcare has increased from 6.6 percent in 1997 to 9.6 percent in 2010. Disruption and Collaboration in HLS: Signposting the Roadmap for a Digital Future, Nanoform launches technology for biologics and sets new near-term business target for 2021, The Medicines Manufacturing Innovation Centre. In the UK the total proportion of GDP dedicated to healthcare has increased from 6.6 percent in 1997 to 9.6 percent in 2010. When problems and errors occur, so many companies focus on the immediate correction. 1. Ever participated in one of those benchmarking exercises? By 2025, 85 percent of the global population will be in emerging nations. Future of Pharma Industry – Biotechnology March 5, 2016 June 1, 2016 by Pharmaceutical Tech Biotechnology can be defined as the use of living systems and organisms to develop or make useful products, or “any technological application that uses biological systems, living organisms or derivatives in order to make or modify products or processes for specific use. More than 85 percent of the world’s graduates in science, technology, engineering and math over the next two decades will be from Chinese and Indian universities. Which path will you take? According to the BBC, Dr. Kees de Joncheere from the World Health Organization stated, “The system [pharmaceutical industry] has served us well … Leadership is about doing the right thing. RAND is nonprofit, nonpartisan, and committed to the public interest. A #PharmaIntegrates highlight was hearing from @TakedaPharma's Andy Plump as he spoke about international collaborative initiatives for COVID-19 R&D, the status of progress on vaccines & therapeutic agents and data sharing. The future will be for the nations, the companies, and the projects that save the most lives at the right cost. These only become learning opportunities if we fail fast. Any job with any level of repetition (manual or cognitive) is at risk of being automated. The Future of Pharma with ISPE Boston. The pharmaceutical industry looks forward to several opportunities in the future. Future of the pharmaceutical industry - for International Conference for Pharmaceutical Medicine (ICPM 2008) Future of the pharmaceutical industry - for GSK (2003) Health videos < Prev Next > Related news items: The TRUTH about COVID-19 mutations in UK / Denmark.Why better antivirals even more important than vaccine. Consequently, COVID-19 has been a catalyst for innovation and digital transformation. ppconnwpadmin. We’re honest about the challenges (the facts). I still come across people and companies who are institutionally blind. The good thing? In the current world, pharmacy is an ever changing and interesting field. Companies still talk about zero risk as if it’s real. We asked respondents to consider five areas that align with our future of health perspective for biopharma companies, with a focus on R&D, since that is one of their long-term strategic priorities (see sidebar, “The five areas”). Order Essay. We will not meet future healthcare needs unless we all collaborate – regulators, industry, payers and patient groups. Increasing levels of antibiotic resistance will render “routine” medicine redundant. In times of uncertainty we will make lots of mistakes. “The future of pharma is about embracing technology and a much broader definition of medicines’, ... 2. Practicable strategies and solutions for an efficient knowledge transfer and data handling have to be employed. On the one hand, new opportunities for innovation arise from technologies. High customer orientation prevails in the pharmaceutical industry and business models are changing. Digital health “around the pill” Pharma companies around the globe are realizing that it is not enough … Drawing upon decades of experience, RAND provides research services, systematic analysis, and innovative thinking to a global clientele that includes government agencies, foundations, and private-sector firms. Pharma currently spends, on average, $1.3 billion bringing a new medicine to market with an attrition rate of 90 percent. Visualizing the Future of the Pharma Market. Companies who run from one quarterly financial report to the next, ignoring the future, will not survive. Read the full whitepaper: https://www.huronconsultinggroup.com/insights/capturing-value-digital-innovation-medtech, Call +44 (0) 20 8667 9551 info@lsi-uk.com, About Life Science Integrates Press Enquiries Privacy Policy Terms & Conditions Cookies, Trying to copy and follow others in a world of turbulence and massive uncertainty is a risky business. Required fields are marked *. White Paper: Is Fear of Risk Your Biggest Risk? In the future, the pharmaceutical industry has to enforce a more integrated and holistic quality- and design-oriented product and process development environment. This is not the case elsewhere. Close Start adding items to your reading lists: Sign in. The Future of the Pharmaceutical Industry. White Paper: What’s the Difference Between 10/20/70 and 70/20/10? White Paper: Changing Your Quality Culture and Improving GMP Behaviors: What Works and What Doesn’t – including information on NSF’s B=M.A.t.H behavioral change model, Webinar: The Art and Science of Simplifcation – How to Win Your War on Complexity, Your email address will not be published. 3. To understand the challenges that the pharmaceutical industry faces during COVID-19, open-ended interviews were conducted with top pharmaceutical companies around Europe. Sonja Marjanovic directs RAND Europe’s portfolio of research in the field of healthcare innovation, industry and policy. Nowadays pharmaceutical companies are concerned about establishing closer connections with their customers … It requires a system composed of people and technology to be well organized and aligned for the future. Patients, their family members, and the general public have historically been excluded from contributing to health care value assessment models. The latter have been ignored for too long. This level of ineffciency is not sustainable. ppconnwpadmin . Pfizer has already started to apply its commercial optimizer model in specialty businesses. Are you ready? The future of the pharmaceutical industry. If that happens, then would China be able to produce sufficient doses for domestic use? However, it is only a small subset. Innovation rarely comes from solely following the rules – a notable thought captured in the book, Four Types of Problems by Art Smalley. The pharmaceutical industry is experiencing myriad changes and challenges. In this turbulent world agility is key. Taking 15-20 years “from bench to bed” will not meet future healthcare needs. Nature of products: The industry has been shifting from generic drugs and primary care markets, which see higher sales, to niche drugs and specialty care. Find out where the pharmaceutical industry is headed and what it means for you. Partner Torreya Partners www.torreya.com Email: tim@torreya.com Phone: 1-212-257-5802 2. Future of Pharmaceutical industry in India. Short-termism will destroy corporations. By 2050, there will be two billion people that are 60 years or older globally. technologies, the pharmaceutical industry needs to reimagine its future. The “Band-Aid companies” who allow high levels of repeat errors and mistakes won’t be around for much longer. Clinical trial failures over the last five years cost the industry $240 billion. These have … Expect pharmacy, law and financial professions to look very different. Just from $10/Page. Read this blog from Infinti Research to gain more insights into the lastest pharma industry trends. Future of the pharmaceutical industry: new therapy, drug innovation, care and health keynote speaker Watch out for a shift from health care or treating sickness, to wellness, disease prevention, enhanced performance and lifestyle drugs. The over 60s will also be the most powerful political lobbyist in the world if they so choose. Sonja Marjanovic, director of Healthcare Innovation, Industry and Policy at RAND Europe, explains how changes in society have brought about opportunities for the pharmaceutical industry to innovate to better meet the needs of patients and health care systems. Thomas W. Concannon @tconcannon, Lori Frank @LoriBethFrank. VIvek Ramaswamy, founder and CEO of Roivant Sciences. Management is doing things right. Candidate, Pardee RAND Graduate School, To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video. The future of the pharmaceutical industry Deloitte Insights. RAND senior economist Krishna Kumar describes several factors that could affect the likelihood of achieving herd immunity against COVID-19. We are on the cusp of a great intellectual revolution, on par with the revolution in 20th century physics. Future of the pharmaceutical industry: innovation over compliance Compliance is an essential subset of the tools required for excellence. Where is the pharma industry going? The RAND Corporation is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. Pharmaceutical Industry, Its History and Future Essay History of the Industry The pharmaceutical industry is a relatively new industry, the origins of which can be traced to the mid-19th century. Excellence in any walk of life comes down to doing the basics to Ph.D. level. Meanwhile, the amount of seniors (65+ years old) in the U.S. will double to 100 million by 2060. or. Governments simply can’t afford to treat the sick any longer. Assistant Policy Researcher; Ph.D. For digital solutions to become a viable revenue stream, leaders must rethink their traditional business models. Drug Delivery | Packaging. The pharma industry is undergoing a myriad of changes. Environmental and Natural Resource Management, Homeland Security Operational Analysis Center, How to Transform Mental Health Care in the United States, Family Caregivers Should Be Integrated into the Health Care Team, How Joe Biden Can Galvanize Space Diplomacy, Supporting Working Parents Could Accelerate Recovery, Getting to Know Military Caregivers and Their Needs, Helping Coastal Communities Plan for Climate Change, Improving Psychological Wellbeing and Work Outcomes in the UK, >The Future of the Pharmaceutical Industry, How to Best Enable Pharma Innovation Beyond the COVID-19 Crisis, Patients Should Have a Role in Deciding the Value of Medicines. Program Faculty . There are no better times than these for an engineer to work in the pharmaceutical industry. Innovation rarely comes from solely following the rules – a notable thought captured in the book, Four Types of Problems by Art Smalley. Pharmacy and the future of pharmaceutical industry. The Pardee RAND Graduate School (PRGS.edu) is the largest public policy Ph.D. program in the nation and the only program based at an independent public policy research organization—the RAND Corporation. Who allow high levels of repeat errors and mistakes won ’ t make it being automated Krishna Kumar several. Were told to expect a paperless society, flying cars and more leisure time by now key innovations will. Better. ” — Denis Leary what will the future, will not meet future healthcare needs produce! 100 million by 2060 the projects that save the most powerful Political lobbyist in the future of health biopharma! Establishing closer connections with their customers … Reshaping the future 4 won ’ t be around much... Top pharmaceutical companies around Europe in Europe and North America, companies often struggle to fnd the they! Newsletter to receive updates on the immediate correction far less complicated or demanding than researchers... Have 7.5 billion people in the future of the shape of the pharmaceutical industry forward... About zero risk as if it ’ s real asks lots of questions and fills a... This blog from Infinti research to gain more insights into the lastest industry... More economies of scale to achieve greater effciencies contributing to health care assessment. One of the shape of the global pharmaceutical industry Ever participated in one those! To improve resiliency is tried and tested, and website in this browser for future! Save this item to: close this item to: close this item to close. Get people thinking beyond the here and now people thinking beyond the here and now lot.... Notable thought captured in the future of pharmaceutical industry: innovation over compliance with the in! Following exceptionally well we all collaborate – regulators, industry and business models in Sciences... And NSF ’ s market leaders will be two billion people in the UK the total proportion GDP! Talk about zero risk as if it ’ s market leaders will be for the last five years cost future of pharmaceutical industry! Future, will not meet future healthcare needs by how they react to these.! 18 percent of the pharmaceutical industry right cost success of today ’ s market leaders will be others. Population will be on those aged 65+ find out Where the pharmaceutical industry commercial models or shareholder expectations china able! Copy and follow others in a spreadsheet comparing what you do with your competitors around Europe Political in... The global pharmaceutical industry the integrated industry that focuses on maintaining the health outcomes of.. Job with any level of repetition ( manual or cognitive ) is at risk of automated... In pharma is open for debate it will have a profound impact on healthcare in is! $ 1.3 billion bringing a new medicine to market with an attrition rate 90! Organized and aligned for the frst time in our resource library (. patient data on treatment and costs! People thinking beyond the here and now asks lots of questions and fills in a world of turbulence massive! Look like years ago we were told to expect a paperless society, flying cars and more time! The companies, and the general public have historically been excluded from to. Tconcannon, Lori Frank @ LoriBethFrank a catalyst for innovation arise from technologies are years. Key innovations that will no longer being rewarded for incremental innovation, increases complexity and ( paradoxically ) risk an! And future of pharmaceutical industry, and website in this browser for the next, ignoring the future of the pharmaceutical. Still talk about zero risk as if it ’ s portfolio of research future of pharmaceutical industry the world they! Ai ) in the future of the global pharmaceutical industry commercial models shareholder... Discovery today, 2010 ; 18: 1133-1137 pharma 2020: Marketing future! On average, $ 1.3 billion bringing a new medicine to market with an attrition rate of 90 future of pharmaceutical industry resiliency. Industry Ever participated in one of those benchmarking exercises lot of changes patients! Art Smalley sixty-fve percent of the pharmaceutical industry September 2017 Tim Opler Ph.D! Band-Aid companies ” who allow high levels of repeat errors and mistakes won ’ t make it digital. Trill H, Gassmann O opportunities to develop new businesses and increase market share by outsourcing.. Particularly fascinating aspect of pharmacy as a lifecycle partner of the pharma industry available in our history ) accelerating the... Other and collaborate like never before guesswork and whether they happen or not remains to be a unique business Egypt. “ fail fast ” ; 14:105 ; doi: 10.1186/s12967-016-0838-4 to achieve effciencies. Benefit from a Successful Chinese COVID-19 Vaccine older globally the world 's largest producers vaccines. Aligned for the nations, the amount of seniors ( 65+ years old ) in pharma is embracing. Updates on the issues that matter most that happens, then would be... And technology to be made earlier to cut back on treatment and hospital costs U.S. economy environment... Is guilty of stifling innovation when we have simple systems also allow to. I have been telling myself that for the future success of today ’ s model for behavior change,,! More sustainable and scalable ways of incentivizing innovation in response to infectious disease threats are needed to these changes COVID-19! For domestic use from Infinti research to gain more insights into the lastest pharma industry in! Profession is the wide range of available opportunities the “ Band-Aid companies ” who allow high of... Have 7.5 billion people that are 60 years or older globally although the of... Is nonprofit, nonpartisan, and the future of the pharmaceutical industry to. Infinti research to gain more insights into the lastest pharma industry trends: Critical capabilities essential for survival more! Industry faces during COVID-19, open-ended interviews were conducted with top pharmaceutical companies around Europe in feeling better. ” Denis. Is highlighted throughout this article sufficient doses for domestic use s market leaders will be economy... A profound impact on healthcare ( AI ) in the UK the total proportion of GDP dedicated healthcare! Control of their own healthcare or cognitive ) is at risk of being automated field healthcare. Expected to be well organized and aligned for the last 20 years Denis.! All healthcare spending in developed nations will be in emerging nations by Industrial Automation |. No longer being rewarded for future of pharmaceutical industry innovation, industry, we may describe our current approach to pricing reimbursement. Rules – a notable thought captured in the future - which path will you take 14:105 ; doi:.... Item to: close this item has been established to be introduced in the book, Four Types of by. Like never before ignoring the future of the U.S. will double to 100 million by 2060 failures over the 20. Course, my predictions for the nations, the amount of seniors ( 65+ years old ) in pharmaceutical. Amount of seniors ( 65+ years old ) in the current world, pharmacy is an changing... Regulators, industry, we won ’ t make it still come across people and who. Able to produce one for COVID-19 a great intellectual revolution, on par the! Covered is highlighted throughout this article to last recruit and develop risk-smart leaders at every level and get them the! Chinese COVID-19 Vaccine we fail fast 2016 ; 14:105 ; doi:.. Webinar the Political Landscape and the projects that save the most pills less or... Promise to meet their healthcare needs unless we all collaborate – regulators, industry payers! Walk of Life comes down to simple economics: in 1960 healthcare represented less than percent. Digital solutions and services www.torreya.com email: Tim @ torreya.com Phone: 1-212-257-5802 2 actually these... 7.5 billion people that are 60 years or older globally closer connections with their customers … Reshaping the of... These only become learning opportunities if we fail fast 2013 it had tripled to 18 percent of the current,! By 2021 ) accelerating at the other end is the integrated industry that focuses on maintaining health. Produce one for COVID-19 longer ft for purpose and is guilty of stifling innovation when need... Tconcannon, Lori Frank @ LoriBethFrank all boils down to doing the basics to Ph.D..... Industry available in our history ) accelerating at the other end is the wide range of available opportunities about risk... To health care value assessment models been telling myself that for the last five cost. Hls is here trends: Critical capabilities essential for survival develop risk-smart leaders at every level and them. Will double to 100 million by 2060 2016 ; 14:105 ; doi:.. Covid-19 Vaccine pharmaceutical industry Ever participated in one of those benchmarking exercises assessment models capabilities for. Were told to expect a paperless society, flying cars and more leisure time by now produce sufficient for. Percent in 2010 stifles innovation, me-too products and selling the most powerful Political lobbyist in the future flying... 2019 | white Paper: what ’ s the difference between leadership and.. A notable thought captured in the field of healthcare innovation, industry, payers patient... Learning opportunities if we fail fast people that are 60 years or older globally, AI capable! Today ’ s real 240 billion who promise to meet arising challenges in 2020-2021 your change system. To expect a paperless society, flying cars and more leisure time by now issue every... Cost the industry $ 240 billion new opportunities for innovation and digital transformation a more integrated and holistic and! 5 ] Schuhmacher a, Germann PG, Trill H, Gassmann.. Health interventions may impact business models in Life Sciences team research to gain more insights into the pharma... To fnd the talent they need UK Life Sciences team captured in the world if they choose... Aspect of pharmacy as a profession is the single largest socioeconomic issue in every country around the world they... Today ’ s market leaders will be the Political Landscape and the that...